Table 5.
Attitudes towards the implementation of a measurement system of infections in ICUs
| |
Weighted estimates for Europe (respondents from 16 countries with >=10 replies) |
Other respondants (66 countries) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
N=1281 |
N=449 |
||||||||||
| |
Agree strongly/ agree |
Disagree/ disagree strongly |
Agree strongly/ agree |
Disagree/ disagree strongly |
||||||||
| % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |||||
|
To what extent do you agree with the following comments | ||||||||||||
| If you cannot measure it, you cannot improve it |
83 |
80 |
85 |
11 |
9 |
13 |
84 |
80 |
87 |
11 |
8 |
14 |
| Monitoring of VAP related measures stimulates quality improvement |
93 |
91 |
94 |
2 |
1 |
3 |
97 |
94 |
98 |
1 |
0 |
3 |
| VAP-related measures in my ICU (if any) are reliable |
54 |
51 |
58 |
12 |
10 |
15 |
66 |
61 |
70 |
8 |
6 |
11 |
| I am willing to implement, or support, a VAP data collection system |
84 |
81 |
86 |
4 |
3 |
6 |
92 |
89 |
94 |
1 |
0 |
3 |
| Clinical diagnosis of VAP is difficult: this makes measurement systems unreliable |
46 |
43 |
50 |
32 |
29 |
36 |
43 |
38 |
47 |
36 |
32 |
41 |
| There is a difference between a definition of VAP for reporting, and a diagnosis of VAP for treatment |
45 |
42 |
49 |
32 |
28 |
35 |
46 |
41 |
50 |
30 |
26 |
35 |
|
Please indicate what actions would facilitate the implementation of a measurement system of infections in ICUs | ||||||||||||
| Timely feed-back of data at ICU level |
92 |
90 |
94 |
1 |
1 |
2 |
96 |
93 |
97 |
0 |
0 |
2 |
| Administrative support |
88 |
86 |
90 |
2 |
1 |
3 |
95 |
92 |
97 |
1 |
0 |
2 |
| Dedicated software / IT resources |
91 |
89 |
93 |
2 |
1 |
3 |
92 |
89 |
94 |
0 |
0 |
2 |
| Reliable data | 95 | 93 | 96 | 1 | 0 | 2 | 96 | 94 | 98 | 0 | 0 | 1 |